The long-term objective of these experiments is to determine the mechanisms by which the expression of a particular glycosyltransferase and its homologs, termed GIcNAc-T V (GnT-V), regulates cell adhesion and tumor progression. Studies have documented an association between specific changes in N-linked oligosaccharides with beta(1,6) branches and oncogenic transformation, increased tumor cell invasiveness, and metastatic potential. Elevation of beta (1,6) branches has also been documented in the progression of human mammary and colon carcinomas. The synthesis of this N-linked oligosaccharide branch is catalyzed by GIcNAc-T V, and the activity of this enzyme is selectively increased after transformation by several oncogenes, and utilizing a mouse model of mammary tumor oncogenesis and progression, elimination of the N-linked beta (1,6) branches branch clearly inhibits tumor invasion and metastasis. Both integrin-based adhesion to the matrix glycoprotein, fibronectin, and N-cadherin-based cell-cell adhesion, as well as the corresponding intracellular signaling pathways are reduced after GnT-V over-expression and increased after eliminating the expression of the enzyme, suggesting mechanisms by which tumor progression can be regulated. A new homolog of GnT-V has been identified in brain tissue and termed GnT-VB.
Aim I will focus on determining how changes in GnT-V activity modulate integrin- and cadherin-based adhesion. In addition, a mouse model of tumor progression will be utilized to study glycan structural changes on adhesion receptors and their signaling pathways in the presence and absence GnT-V activity to test if changes can be detected in vivo.
Aim II will focus on investigating the regulation and function of GnT-VB. Brain glycoproteins that are endogenous acceptors will be identified, and techniques for expression of siRNA will be used to test if GnT-VB expression in vivo during brain development functions to regulate cell migration/adhesion. GnT-VB null mice and GnT-V/GnT-VB double null mice will be generated.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA064462-11
Application #
7214793
Study Section
Special Emphasis Panel (ZRG1-SSS-2 (02))
Program Officer
Jhappan, Chamelli
Project Start
1995-09-30
Project End
2010-02-28
Budget Start
2007-03-01
Budget End
2008-02-29
Support Year
11
Fiscal Year
2007
Total Cost
$348,623
Indirect Cost
Name
University of Georgia
Department
Type
Organized Research Units
DUNS #
004315578
City
Athens
State
GA
Country
United States
Zip Code
30602
Lee, Jin Kyu; Matthews, Russell T; Lim, Jae-Min et al. (2012) Developmental expression of the neuron-specific N-acetylglucosaminyltransferase Vb (GnT-Vb/IX) and identification of its in vivo glycan products in comparison with those of its paralog, GnT-V. J Biol Chem 287:28526-36
Abbott, Karen L; Pierce, J Michael (2010) Lectin-based glycoproteomic techniques for the enrichment and identification of potential biomarkers. Methods Enzymol 480:461-76
Guo, Hua-Bei; Johnson, Heather; Randolph, Matthew et al. (2010) Specific posttranslational modification regulates early events in mammary carcinoma formation. Proc Natl Acad Sci U S A 107:21116-21
Abbott, Karen L; Lim, Jae-Min; Wells, Lance et al. (2010) Identification of candidate biomarkers with cancer-specific glycosylation in the tissue and serum of endometrioid ovarian cancer patients by glycoproteomic analysis. Proteomics 10:470-81
Alvarez-Manilla, Gerardo; Troupe, Karolyn; Fleming, Maria et al. (2010) Comparison of the substrate specificities and catalytic properties of the sister N-acetylglucosaminyltransferases, GnT-V and GnT-Vb (IX). Glycobiology 20:166-74
Guo, Hua-Bei; Johnson, Heather; Randolph, Matthew et al. (2009) Knockdown of GnT-Va expression inhibits ligand-induced downregulation of the epidermal growth factor receptor and intracellular signaling by inhibiting receptor endocytosis. Glycobiology 19:547-59
Guo, Hua-Bei; Johnson, Heather; Randolph, Matthew et al. (2009) Regulation of homotypic cell-cell adhesion by branched N-glycosylation of N-cadherin extracellular EC2 and EC3 domains. J Biol Chem 284:34986-97
Abbott, Karen L; Matthews, Russell T; Pierce, Michael (2008) Receptor tyrosine phosphatase beta (RPTPbeta) activity and signaling are attenuated by glycosylation and subsequent cell surface galectin-1 binding. J Biol Chem 283:33026-35
Abbott, Karen L; Nairn, Alison V; Hall, Erica M et al. (2008) Focused glycomic analysis of the N-linked glycan biosynthetic pathway in ovarian cancer. Proteomics 8:3210-20
Abbott, Karen L; Aoki, Kazuhiro; Lim, Jae-Min et al. (2008) Targeted glycoproteomic identification of biomarkers for human breast carcinoma. J Proteome Res 7:1470-80

Showing the most recent 10 out of 16 publications